Syntara (ASX:SNT) Price-to-Tangible-Book : 3.29 (As of Jun. 25, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Syntara Price-to-Tangible-Book?

As of today (2024-06-25), Syntara's share price is A$0.023. Syntara's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.01. Hence, Syntara's Price to Tangible Book Ratio of today is 3.29.

The historical rank and industry rank for Syntara's Price-to-Tangible-Book or its related term are showing as below:

ASX:SNT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.3 Med: 6.11 Max: 70
Current: 2.3

During the past 13 years, Syntara's highest Price to Tangible Book Ratio was 70.00. The lowest was 1.30. And the median was 6.11.

ASX:SNT's Price-to-Tangible-Book is ranked worse than
52.78% of 862 companies
in the Drug Manufacturers industry
Industry Median: 2.245 vs ASX:SNT: 2.30

A closely related ratio is called PB Ratio. As of today, Syntara's share price is A$0.023. Syntara's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.01. Hence, Syntara's P/B Ratio of today is 2.88.

Syntara Price-to-Tangible-Book Historical Data

The historical data trend for Syntara's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Price-to-Tangible-Book Chart

Syntara Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

7.22

70.00

22.25

3.61

4.08

Syntara Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															24.00	3.61	3.05	4.08	2.86

Competitive Comparison of Syntara's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syntara's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Syntara's Price-to-Tangible-Book falls into.

Syntara Price-to-Tangible-Book Calculation

Syntara's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.023	/	0.007
	=	3.29

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Syntara Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Syntara's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara (ASX:SNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

UUDA:Germany

Address

20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.pharmaxis.com.au

Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.